19 Sep 2019 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham provides an update on the company's lead product RECCE 327, including its progress with manufacturing, securing patents and presenting to a global audience.
17 Sep 2019 - Tinybeans Limited (ASX:TNY) Founder & CEO, Eddie Geller discusses the company's FY19 results, growth users to its platform, new services and strategy.
16 Sep 2019 - AdAlta Limited (ASX:1AD) Executive Chairman, Dr Paul MacLeman talks about the company's collaboration with GE Healthcare.
16 Sep 2019 - Aus Tin Mining Limited (ASX:ANW) CEO, Peter Williams discusses the company’s high-grade exploration results from its northern NSW project, plus how it’s poised to benefit from the rise of ‘critical minerals’ designation.
16 Sep 2019 - LBT Innovations Limited (ASX:LBT) Managing Director and CEO, Brent Barnes, talks FY19 results and outlook, including adoption of the company's culture plate reading device APAS Independence, the sales process and regulatory approval.
13 Sep 2019 - Healthia Limited (ASX:HLA) Group CEO & Managing Director, Wesley Coote and Chairman, Dr Glen Richards talk about the company's FY19 results and its model of acquiring podiatry and physiotherapy clinics.
11 Sep 2019 - BluGlass Limited (ASX:BLG) Managing Director Giles Bourne discusses partnering with LED lighting developer Bridgelux, enabling smaller and cheaper LEDs, and what the future holds with BLG’s new facility.
10 Sep 2019 - Cashwerkz Limited (ASX:CWZ) Director, John Nantes talks FY19 results and outlook, including growth in distribution through adviser platforms, neo-banks and new functionality.
06 Sep 2019 - Argo Investments Limited (ASX:ARG) Managing Director, Jason Beddow talks about the Listed Investment Company’s performance, record low interest rates and finding long-term value.
05 Sep 2019 - Elixinol Global Limited (ASX:EXL) Founder and Chief Innovation Officer, Paul Benhaim talks about the company's range of hemp products, its focus on the hemp-derived CBD market in the US, regulatory acceptance and outlook.
